Twist Bioscience (TWST) Treasury Shares (2017 - 2026)

Twist Bioscience has disclosed Treasury Shares across 10 years of filings, most recently posting $2.8 million for Q1 2026.

• In Q1 2026, Treasury Shares rose 35.16% year-over-year to $2.8 million; the TTM figure through Mar 2026 stood at $2.8 million (up 35.16% YoY), while the FY2025 annual figure was $1.9 million, up 61.41% from the prior year.
• Treasury Shares retreated to $2.8 million in Q1 2026, from $3.0 million in the prior quarter.
• Over the last five years, Treasury Shares for TWST reached as high as $3.0 million in Q4 2025 and fell as low as $700000.0 in Q2 2023.
• The 5-year median for Treasury Shares is $1.4 million (2023), against an average of $1.6 million.
• Annual changes were most pronounced in 2022 — Treasury Shares surged 173133.7% — and 2023, when it plunged 44.27%.
• A 5-year view of Treasury Shares shows it stood at $759000.0 in 2022, then jumped by 85.11% to $1.4 million in 2023, then jumped by 46.83% to $2.1 million in 2024, then soared by 46.0% to $3.0 million in 2025, then decreased by 5.81% to $2.8 million in 2026.
• According to Business Quant data, Treasury Shares over the past three periods registered $2.8 million, $3.0 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.